Literature DB >> 164014

Interferon action II. Membrane-bound alkaline ribonuclease activity in chick embryo cells manifesting interferon-mediated interference.

P I Marcus, T M Terry, S Levine.   

Abstract

Membrane fractions from chick embryo cells manifesting viral interference mediated by interferon or poly(I)-poly(C) contain high levels of an alkaline ribonuclease. Enhanced RNase activity is not observed when inhibitors of cell protein or RNA synthesis are present during interferon treatment, or when heterologous interferon is used. The RNase associated with comparable membrane fractions from cells treated with mock-interferon is about 1/10 as active, and shows qualitative differences. In principle, divergent views of interferon action may be reconciled to a common mode of action by postulating that viral interference results from a newly induced or activated RNase of cellular origin and proper specificity that acts to reduce the accumulation and functional capacity of newly synthesized viral RNAs, particularly mRNA. Previous data in support of interferon's acting to inhibit virion-derived transcription in vivo are now interpreted as demonstrating enhanced degradation of viral transcripts (mRNA).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164014      PMCID: PMC432266          DOI: 10.1073/pnas.72.1.182

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Ribonuclease. IX. Further studies on ribonuclease inhibitor.

Authors:  J S ROTH
Journal:  Biochim Biophys Acta       Date:  1962-12-31

2.  Ribonuclease. V. Studies on the properties and distribution of ribonuclease inhibitor in the rat.

Authors:  J S ROTH
Journal:  Biochim Biophys Acta       Date:  1956-07

3.  Effect of temperature-sensitive mutations on the virion-associated RNA transcriptase of vesicular stomatitis virus.

Authors:  J F Szilágyi; C R Pringle
Journal:  J Mol Biol       Date:  1972-11-14       Impact factor: 5.469

4.  Properties of the product synthesized by vesicular stomatitis virus particles.

Authors:  D H Bishop; P Roy
Journal:  J Mol Biol       Date:  1971-06-28       Impact factor: 5.469

5.  The role of cytoplasmic membranes in poliovirus biosynthesis.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

6.  Inhibition of poliovirus RNA synthesis by supraoptimal temperatures.

Authors:  M Y Fiszman; D Bucchini; M Girard; A Lwoff
Journal:  J Gen Virol       Date:  1970-02       Impact factor: 3.891

7.  Interferon-mediated inhibition of virion-directed transcription.

Authors:  E K Manders; J G Tilles; A S Huang
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

8.  Selective inhibition of viral protein accumulation in interferon-treated cells; nondiscriminate inhibition of the translation of added viral and cellular messenger RNAs in their extracts.

Authors:  S L Gupta; W D Graziadei; H Weideli; M L Sopori; P Lengyel
Journal:  Virology       Date:  1974-01       Impact factor: 3.616

9.  Molecular basis of interferon action: inhibition of viral RNA translation.

Authors:  P I Marcus; J M Salb
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

10.  Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase.

Authors:  P I Marcus; D L Engelhardt; J M Hunt; M J Sekellick
Journal:  Science       Date:  1971-11-05       Impact factor: 47.728

View more
  6 in total

Review 1.  Antiviral activity of interferons.

Authors:  R M Friedman
Journal:  Bacteriol Rev       Date:  1977-09

Review 2.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

3.  RNase activity in human interferon preparations.

Authors:  R A Winchurch; T P Karpetsky; C C Levy; K Cantell
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

4.  Formation and characteristics of reovirus subviral particles in interferon-treated mouse L cells.

Authors:  R L Galster; P Lengyel
Journal:  Nucleic Acids Res       Date:  1976-03       Impact factor: 16.971

5.  Lack of detectable nuclease activity in highly purified preparations of murine fibroblast interferon.

Authors:  J N Wood
Journal:  Mol Biol Rep       Date:  1979-12-31       Impact factor: 2.316

6.  Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract.

Authors:  G C Sen; S L Gupta; G E Brown; B Lebleu; M A Rebello; P Lengyel
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.